People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...

Retail chatter around Crinetics Pharmaceuticals picked up late Sunday after the company released long-term data for its oral ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

Crinetics shares PATHFNDR trial data showing oral Palsonify maintained hormone and symptom control in acromegaly patients ...

Acromegaly is associated with increased mortality, mostly attributed to cardiovascular, cerebrovascular and respiratory abnormalities. 1 Tight biochemical control of the growth hormone axis is ...

Adults with acromegaly have more comorbidities and are prescribed more concomitant medications than those without acromegaly, according to study findings published in Pituitary. “Acromegaly is a ...

New research in Germany indicates that acromegaly might affect millions more people than previously thought. In the past, it was estimated that the world-wide prevalence of acromegaly was only ...

Creating custom furniture is a problem-solving process. But when Anthony Bucher's health began to decline, it was a problem he couldn't solve on his own.

S AN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San ...

Adults treated for acromegaly at a medical center in Turkey do not have an increased risk for cancer compared with the general population, according to study findings published in Endocrine ...